Search Results - "GODEAU, Bertrand"

Thrombopoietin receptor agonists: ten years later by Ghanima, Waleed, Cooper, Nichola, Rodeghiero, Francesco, Godeau, Bertrand, Bussel, James B

“…The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008…”
Get full text

Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination by Lee, Eun‐Ju, Cines, Douglas B., Gernsheimer, Terry, Kessler, Craig, Michel, Marc, Tarantino, Michael D., Semple, John W., Arnold, Donald M., Godeau, Bertrand, Lambert, Michele P., Bussel, James B.

Get full text

Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France by Moulis, Guillaume, Palmaro, Aurore, Montastruc, Jean-Louis, Godeau, Bertrand, Lapeyre-Mestre, Maryse, Sailler, Laurent

“…The epidemiology of immune thrombocytopenia (ITP) is not well known. The purpose of this study was to assess ITP incidence at a nationwide level (France) with…”
Get full text

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment by Ghanima, Waleed, Godeau, Bertrand, Cines, Douglas B., Bussel, James B.

“…The paradigm for managing primary immune thrombocytopenia (ITP) in adults has changed with the advent of rituximab and thrombopoietin receptor agonists…”
Get full text

How we manage immune thrombocytopenia in the elderly by Mahévas, Matthieu, Michel, Marc, Godeau, Bertrand

“…Summary With prolonged life expectancy, immune thrombocytopenia (ITP) is frequent in elderly people. In this setting, ITP diagnosis is challenging because of…”
Get full text

Updated international consensus report on the investigation and management of primary immune thrombocytopenia by Provan, Drew, Arnold, Donald M., Bussel, James B., Chong, Beng H., Cooper, Nichola, Gernsheimer, Terry, Ghanima, Waleed, Godeau, Bertrand, González-López, Tomás José, Grainger, John, Hou, Ming, Kruse, Caroline, McDonald, Vickie, Michel, Marc, Newland, Adrian C., Pavord, Sue, Rodeghiero, Francesco, Scully, Marie, Tomiyama, Yoshiaki, Wong, Raymond S., Zaja, Francesco, Kuter, David J.

“…Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia…”
Get full text

Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia by Deshayes, Samuel, Godeau, Bertrand

“…Less than 40% of patients with newly diagnosed adult immune thrombocytopenia will show spontaneous recovery within 12 months. Therefore, second-line treatments…”
Get full text

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study by Michel, Marc, Ruggeri, Marco, Gonzalez-Lopez, Tomas Jose, Alkindi, Salam, Cheze, Stéphane, Ghanima, Waleed, Tvedt, Tor Henrik Anderson, Ebbo, Mikael, Terriou, Louis, Bussel, James B., Godeau, Bertrand

“…Management of immune thrombocytopenia (ITP) during pregnancy can be challenging because treatment choices are limited. Thrombopoietin receptor agonists…”
Get full text

Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia by Crickx, Etienne, Audia, Sylvain, Robbins, Ailsa, Boutboul, David, Comont, Thibault, Cheminant, Morgane, Oksenhendler, Eric, Godeau, Bertrand, Michel, Marc, Mahevas, Matthieu

Get full text

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group by Rodeghiero, Francesco, Stasi, Roberto, Gernsheimer, Terry, Michel, Marc, Provan, Drew, Arnold, Donald M., Bussel, James B., Cines, Douglas B., Chong, Beng H., Cooper, Nichola, Godeau, Bertrand, Lechner, Klaus, Mazzucconi, Maria Gabriella, McMillan, Robert, Sanz, Miguel A., Imbach, Paul, Blanchette, Victor, Kühne, Thomas, Ruggeri, Marco, George, James N.

“…Diagnosis and management of immune thrombocytopenic purpura (ITP) remain largely dependent on clinical expertise and observations more than on evidence derived…”
Get full text

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia by González-Porras, José R., Godeau, Bertrand, Carpenedo, Monica

“…Primary immune thrombocytopenia (ITP) is a bleeding disorder that conventionally has been treated with steroids or other immunosuppressive treatments. The…”
Get full text

International consensus report on the investigation and management of primary immune thrombocytopenia by Provan, Drew, Stasi, Roberto, Newland, Adrian C., Blanchette, Victor S., Bolton-Maggs, Paula, Bussel, James B., Chong, Beng H., Cines, Douglas B., Gernsheimer, Terry B., Godeau, Bertrand, Grainger, John, Greer, Ian, Hunt, Beverley J., Imbach, Paul A., Lyons, Gordon, McMillan, Robert, Rodeghiero, Francesco, Sanz, Miguel A., Tarantino, Michael, Watson, Shirley, Young, Joan, Kuter, David J.

“…Previously published guidelines for the diagnosis and management of primary immune thrombocytopenia (ITP) require updating largely due to the introduction of…”
Get full text

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring by Moulis, Guillaume, Crickx, Etienne, Thomas, Laure, Massy, Nathalie, Mahévas, Matthieu, Valnet-Rabier, Marie-Blanche, Atzenhoffer, Marina, Michel, Marc, Godeau, Bertrand, Bagheri, Haleh, Salvo, Francesco

Get full text

Delayed hemolytic transfusion reaction in adult sickle‐cell disease: presentations, outcomes, and treatments of 99 referral center episodes by Habibi, Anoosha, Mekontso‐Dessap, Armand, Guillaud, Constance, Michel, Marc, Razazi, Keyvan, Khellaf, Mehdi, Chami, Btissam, Bachir, Dora, Rieux, Claire, Melica, Giovanna, Godeau, Bertrand, Galacteros, Frédéric, Bartolucci, Pablo, Pirenne, France

“…Delayed hemolytic transfusion reaction (DHTR) is one of the most feared complications of sickle‐cell disease (SCD). We retrospectively analyzed the clinical…”
Get full text

The temporary use of thrombopoietin‐receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study by Mahévas, Matthieu, Fain, Olivier, Ebbo, Mikael, Roudot‐Thoraval, Françoise, Limal, Nicolas, Khellaf, Mehdi, Schleinitz, Nicolas, Bierling, Philippe, Languille, Laeticia, Godeau, Bertrand, Michel, Marc

“…Summary Thrombopoietin‐receptor agonists (Tpo‐RAs) are highly effective in immune thrombocytopenia (ITP). Recently, cases of durable remission after Tpo‐RA…”
Get full text

Long-term complications of splenectomy in adult immune thrombocytopenia by Thai, Lan-Huong, Mahévas, Matthieu, Roudot-Thoraval, Françoise, Limal, Nicolas, Languille, Laetitia, Dumas, Guillaume, Khellaf, Mehdi, Bierling, Philippe, Michel, Marc, Godeau, Bertrand

“…The recent large decrease in splenectomy use for chronic immune thrombocytopenia (ITP) is partly due to still-unsolved questions about long-term safety. We…”
Get full text

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group by Rodeghiero, Francesco, Michel, Marc, Gernsheimer, Terry, Ruggeri, Marco, Blanchette, Victor, Bussel, James B., Cines, Douglas B., Cooper, Nichola, Godeau, Bertrand, Greinacher, Andreas, Imbach, Paul, Khellaf, Mehdi, Klaassen, Robert J., Kühne, Thomas, Liebman, Howard, Mazzucconi, Maria Gabriella, Newland, Adrian, Pabinger, Ingrid, Tosetto, Alberto, Stasi, Roberto

“…In a previous publication on new terminology, definitions, and outcome criteria for immune thrombocytopenia (ITP), the International Working Group (IWG) on ITP…”
Get full text

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients by Khellaf, Mehdi, Charles-Nelson, Anaïs, Fain, Olivier, Terriou, Louis, Viallard, Jean-François, Cheze, Stéphane, Graveleau, Julie, Slama, Borhane, Audia, Sylvain, Ebbo, Mikael, Le Guenno, Guillaume, Cliquennois, Manuel, Salles, Gilles, Bonmati, Caroline, Teillet, France, Galicier, Lionel, Hot, Arnaud, Lambotte, Olivier, Lefrère, François, Sacko, Salimatou, Kengue, Dieudonné Kilendo, Bierling, Philippe, Roudot-Thoraval, Françoise, Michel, Marc, Godeau, Bertrand

“…We conducted a prospective multicenter registry of 248 adult patients with immune thrombocytopenia (ITP) treated with rituximab to assess safety. We also…”
Get full text

A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study) by Michel, Marc, Terriou, Louis, Roudot‐Thoraval, Francoise, Hamidou, Mohamed, Ebbo, Mikael, Le Guenno, Guillaume, Galicier, Lionel, Audia, Sylvain, Royer, Bruno, Morin, Anne‐Sophie, Marie Michot, Jean, Jaccard, Arnaud, Frenzel, Laurent, Khellaf, Mehdi, Godeau, Bertrand

“…This Phase 3 multicentre randomized double‐blind and placebo‐controlled trial aimed to compare the efficacy and safety of rituximab (RTX) to placebo for…”
Get full text

Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort by Moulis, Guillaume, Germain, Johanne, Comont, Thibault, Brun, Natacha, Dingremont, Claire, Castel, Brice, Arista, Sophie, Sailler, Laurent, Lapeyre‐Mestre, Maryse, Beyne‐Rauzy, Odile, Godeau, Bertrand, Adoue, Daniel

“…The clinical epidemiology of immune thrombocytopenia (ITP) is not well known in adults. This study was aimed at assessing the clinical epidemiology of incident…”
Get full text